Disclosures for "A Novel Approach for Operationalizing Imaging Import from External Institutions "
-
Miss Aggarwal has nothing to disclose.
-
Ms. Kavanaugh has nothing to disclose.
-
Ms. Santos has nothing to disclose.
-
Miss Gilliard has nothing to disclose.
-
An immediate family member of Miss Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair and Company. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. An immediate family member of Miss Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. An immediate family member of Miss Wilson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of an immediate family member of Miss Wilson has received research support from Roche/Genentech.
-
Ms. Giardino has nothing to disclose.
-
Ms. Jefferson has nothing to disclose.
-
Ms. Elahi has nothing to disclose.
-
Mr. Passarella has nothing to disclose.
-
Mr. Honeywell has stock in Apple and Johnson & Johnson.
-
Dr. Gitelman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ViyaMD.
-
Miss Lee has nothing to disclose.
-
Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .